1,3-dipropyl-8-cyclopentylxanthine has been researched along with Nasopharyngeal Neoplasms in 1 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
Nasopharyngeal Neoplasms: Tumors or cancer of the NASOPHARYNX.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pan, S | 1 |
| Zhang, X | 1 |
| Guo, Y | 1 |
| Li, Y | 1 |
1 other study available for 1,3-dipropyl-8-cyclopentylxanthine and Nasopharyngeal Neoplasms
| Article | Year |
|---|---|
DPCPX induces Bim-dependent apoptosis in nasopharyngeal carcinoma cells.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Mice; Mice, Nude; Nasopharyngeal C | 2022 |